Clincosm LogoSign in Get a demo

Primary Peritoneal Cancer

Showing 51 - 75 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (pegylated liposomal

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • pegylated liposomal doxorubicin (PLD)
  • +2 more
  • Phoenix, Arizona
  • +135 more
Sep 24, 2019

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (LY2228820, Carboplatin, Placebo)

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Phoenix, Arizona
  • +29 more
Aug 28, 2019

High Volume Cancer Center by Black Ovarian Cancer: A Qualitative

Completed
  • Ovarian Cancer
  • +2 more
  • semi-structured interviews
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2019

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (Ganetespib, Paclitaxel)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Innsbruck, Austria
  • +9 more
Jun 25, 2019

Ovarian Epithelial Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (Gimatecan 0.6mg/m2/d, 0.8mg/m2/d,

Recruiting
  • Ovarian Epithelial Cancer
  • +2 more
  • Gimatecan 0.6mg/m2/d
  • +2 more
  • Beijing, Beijing, China
    Beijing Tumor Hospital
Jul 21, 2019

Ovarian Cancer, Primary Peritoneal Cancer Trial in Ghent (Cytoreductive surgery, IPEC with Cisplatin (75mg/m²), IPEC with

Unknown status
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Cytoreductive surgery
  • +4 more
  • Ghent, East-Flanders, Belgium
    UZ Ghent
Jan 14, 2019

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Boston (bevacizumab, erlotinib, paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 26, 2018

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Boston (CRLX101)

Completed
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jun 28, 2018

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Italy, Russian Federation, United States

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Mar 17, 2018

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Columbus (carboplatin, Bevacizumab, Paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Columbus, Ohio
    The Ohio State University Medical Center
Feb 7, 2018

Fallopian Tube, Primary Peritoneal Cancer, Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian Trial in

Completed
  • Fallopian Tube
  • +2 more
  • Groningen, Netherlands
  • +2 more
Dec 28, 2017

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Minneapolis (Fludarabine, Cyclophosphamide,

Completed
Has Results
  • Ovarian Cancer
  • +3 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG386 plus PLD, Placebo plus PLD)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • AMG386 plus PLD
  • Placebo plus PLD
  • Los Angeles, California
  • +105 more
Nov 27, 2017

Non-hematologic Malignancies, Metastatic Melanoma, Breast Cancer Trial (ABT-888, Temozolomide)

Completed
  • Non-hematologic Malignancies
  • +6 more
  • (no location specified)
Nov 17, 2017

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Salt Lake City (regorafenib)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 7, 2017

Ovarian Cancer, Primary Peritoneal Cancer Trial in Philadelphia (DCVax-L and T Cells)

Withdrawn
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • DCVax-L and T Cells
  • Philadelphia, Pennsylvania
    University of Pennsylania
Apr 28, 2017

Ovarian Cancer, Primary Peritoneal Cancer, Serous Carcinoma Cancer Trial in Canada, United States (ABT-888, Cyclophosphamide)

Completed
Has Results
  • Ovarian Cancer
  • +4 more
  • Davis, California
  • +9 more
Mar 16, 2017

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Paclitaxel)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • AMG 386
  • +2 more
  • Phoenix, Arizona
  • +224 more
Dec 14, 2016

Epithelial Ovarian Cancer, Primary Peritoneal Cancer Trial in Orange (Topotecan, Cisplatin, Paclitaxel)

Completed
  • Epithelial Ovarian Cancer
  • Primary Peritoneal Cancer
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 6, 2016

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Hilliard (Paclitaxel, Carboplatin, Bevacizumab)

Unknown status
  • Ovarian Cancer
  • +3 more
  • Hilliard, Ohio
    OSU Gyn Oncology at Mill Run
Oct 12, 2016

Carcinoma, Fallopian Tube Cancer, Ovarian Cancer Trial in Australia, Belgium, Spain (AMG 386, paclitaxel and carboplatin)

Completed
  • Carcinoma
  • +3 more
  • AMG 386, paclitaxel and carboplatin
  • Footscray, Victoria, Australia
  • +7 more
Oct 13, 2015

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Providence (Panitumumab)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Panitumumab
  • Providence, Rhode Island
    Women & Infants' Hospital
Jul 28, 2015

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Chicago, Evanston (Arm A: Vitamin D3 Group, Placebo)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Arm A: Vitamin D3 Group
  • Placebo
  • Chicago, Illinois
  • +1 more
Jul 1, 2015

Ovarian Cancer, Primary Peritoneal Cancer, Other Gynecological Cancers Trial in Ramat Gan (Tai-chi/Qi-gong)

Withdrawn
  • Ovarian Cancer
  • +2 more
  • Tai-chi/Qi-gong
  • Ramat Gan, Israel
    Sheba Hospital
Jun 10, 2015

Ovarian Epithelial Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Shenyang (p53 gene, Cisplatin, Paclitaxel)

Unknown status
  • Ovarian Epithelial Cancer
  • +2 more
  • p53 gene
  • +2 more
  • Shenyang, Liaoning, China
    xijing hospital in China Medical University
Apr 30, 2015